Our leadership is deeply committed to developing first-in-class medicines and bringing together a dedicated team of experts to achieve this goal.

Enrique Conterno

Enrique Conterno

Chief Executive Officer
Percy H. Carter, M.B.A., Ph.D.

Percy H. Carter, M.B.A., Ph.D.

Chief Scientific Officer
Kirk Christoffersen

Kirk Christoffersen

Chief Business Officer
Christine L. Chung

Christine L. Chung

Senior Vice President, China Operations
Pat Cotroneo

Pat Cotroneo

Chief Financial Officer
Mark Eisner, M.D., M.P.H.

Mark Eisner, M.D., M.P.H.

Chief Medical Officer
Richard Farley

Richard Farley

Vice President, Human Resources
R. Wayne Frost, Pharm.D., J.D.

R. Wayne Frost, Pharm.D., J.D.

Senior Vice President, Regulatory Affairs
Elias Kouchakji, M.D.

Elias Kouchakji, M.D.

Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
Michael D. Lowenstein, J.D.

Michael D. Lowenstein, J.D.

Chief Legal Officer
Michael J. Martinelli, Ph.D.

Michael J. Martinelli, Ph.D.

Senior Vice President, Technical Development
Leanne C. Price, J.D.

Leanne C. Price, J.D.

Chief Intellectual Property Officer
Thane Wettig

Thane Wettig

Chief Commercial Officer

Our Leadership

We are putting our substantial expertise to work in developing and commercializing novel therapeutics.